Key facts
- This page summarizes Jonathan C. Roberts's Form 4 filing for CVS HEALTH Corp (CVS).
- 1 reported transaction and 8 derivative rows are listed below.
- Accepted by SEC: 05 Apr 2022, 17:43.
Jonathan C. Roberts - 01 Apr 2022 Form 4 Insider Report for CVS HEALTH Corp (CVS)
- Reporting relationship
- EVP & Chief Operating Officer
- Issuer ticker
- CVS
- Reported as of
- 01 Apr 2022
- Net transaction value
- +$2,627,026
- SEC form
- 4
- Accepted by SEC
- 05 Apr 2022, 17:43:33 UTC
- Prior SEC filing
- 23 Feb 2022
- Source filing
- View source filing
- Reporting owner signature
- Jonathan C. Roberts
Source evidence
Original filing metadata and source links for verification.
4 source fields
Reporting owner
1 detail
Key filing fact
Jonathan C. Roberts filed Form 4 for CVS HEALTH Corp (CVS) on 05 Apr 2022.
Change
- Previous filing in this sequence was filed on 23 Feb 2022.
- Current net transaction value: +$2,627,026.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
CVS
holding
Common Stock
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 426,025
- Date
- 01 Apr 2022
- Ownership
- Direct
CVS
holding
Common Stock
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 38,192
- Date
- 01 Apr 2022
- Ownership
- By GRAT
CVS
holding
Common Stock (restricted)
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 12,812
- Date
- 01 Apr 2022
- Ownership
- Direct
CVS
holding
ESOP Common Stock
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 6,156
- Date
- 01 Apr 2022
- Ownership
- By ESOP
CVS
holding
Stock Unit
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 341,392
- Date
- 01 Apr 2022
- Ownership
- Direct
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
CVS
transaction
Derivative
Stock Option
Award
- Transaction value
- $2,627,026
- Shares
- +25,987
- Change %
- Price
- $101.09
- Shares after
- 25,987
- Date
- 01 Apr 2022
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 25,987
- Exercise price
- $101.09
- Footnotes
- F1
CVS
holding
Derivative
Phantom Stock Credits
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 1,416
- Date
- 01 Apr 2022
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 1,416
- Exercise price
- $1.00
- Footnotes
- F2
CVS
holding
Derivative
Stock Option
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 161,318
- Date
- 01 Apr 2022
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 161,318
- Exercise price
- $104.82
- Footnotes
- F3
CVS
holding
Derivative
Stock Option
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 200,358
- Date
- 01 Apr 2022
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 200,358
- Exercise price
- $78.05
- Footnotes
- F4
CVS
holding
Derivative
Stock Option
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 248,131
- Date
- 01 Apr 2022
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 248,131
- Exercise price
- $62.21
- Footnotes
- F5
CVS
holding
Derivative
Stock Option
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 303,010
- Date
- 01 Apr 2022
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 303,010
- Exercise price
- $54.19
- Footnotes
- F6
CVS
holding
Derivative
Stock Option
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 239,355
- Date
- 01 Apr 2022
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 239,355
- Exercise price
- $58.34
- Footnotes
- F7, F8
CVS
holding
Derivative
Stock Option
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 172,772
- Date
- 01 Apr 2022
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 172,772
- Exercise price
- $74.30
- Footnotes
- F9
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 9 footnotes
Footnote F1
Option becomes exercisable in four equal installments, commencing 4/1/2023.
Footnote F2
Reflects year-end company-match share credits under a non-qualified deferred compensation plan; share credits are payable in cash only, at such time as has been elected by the reporting person.
Footnote F3
Option became exercisable in four equal annual installments, commencing 4/1/2017.
Footnote F4
Option became exercisable in four equal annual installments, commencing 4/3/2018.
Footnote F5
Option became exercisable in four equal annual installments, commencing 4/1/2019.
Footnote F6
Option became exercisable in four equal annual installments, commencing 4/1/2020.
Footnote F7
The number of shares subject to the option were calculated using a 30-day average price.
Footnote F8
Options became exercisable in four equal installments, commencing 4/1/2021.
Footnote F9
Option becomes exercisable in four equal installments, commencing 4/1/2022.